What is the initial workup for a patient suspected of having osteosarcoma (bone cancer)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup for Suspected Osteosarcoma

The initial workup for a patient suspected of having osteosarcoma should include imaging of the primary site (contrast-enhanced MRI with or without CT), chest imaging including chest CT, and head-to-toe FDG-PET/CT and/or bone scan, along with laboratory tests for ALP and LDH levels. 1

Imaging Studies

Primary Site Evaluation

  1. Plain Radiographs

    • First imaging study to be performed
    • Key findings: cortical destruction, irregular reactive bone formation, "sunburst" appearance, Codman's triangle, and new bone formation in soft tissues 2
    • Helps establish initial suspicion of osteosarcoma
  2. MRI with Contrast

    • Most important imaging modality for local staging
    • Provides excellent soft tissue contrast
    • Defines:
      • Extent of lesion within bone and soft tissues
      • Presence of "skip" metastases
      • Anatomic relationships with surrounding structures
      • Involvement of neurovascular structures
      • Joint involvement 1
  3. CT Scan (optional)

    • May be used as an adjunct to conventional radiography
    • Better evaluation of bone matrix and cortical destruction 3

Metastatic Workup

  1. Chest CT

    • Mandatory for all patients
    • Lung is the most common site of metastasis 1
  2. Bone Scan

    • Detects additional synchronous bone lesions
    • Identifies osseous metastases 1
  3. FDG-PET/CT

    • Head-to-toe evaluation
    • Detects both bone and soft tissue metastases
    • Helps in overall staging 1, 3

Laboratory Studies

  1. Alkaline Phosphatase (ALP)

    • Frequently elevated in osteosarcoma
    • Prognostic value 1
  2. Lactate Dehydrogenase (LDH)

    • Significantly higher in patients with metastatic disease
    • Important prognostic marker 1

Biopsy

  • Required for definitive diagnosis
  • Reveals grade of tumor
  • Should be planned by the surgeon who will perform the definitive surgery
  • Biopsy tract must be considered contaminated and should be resected during definitive surgery 2

Genetic Considerations

  • Consider genetic consultation and testing for patients with:
    • Family history of bone sarcomas
    • Personal history of other cancers
  • Genetic syndromes associated with osteosarcoma:
    • Li-Fraumeni syndrome
    • Hereditary retinoblastoma
    • Rothmund-Thomson syndrome type 2
    • Bloom syndrome
    • Werner syndrome
    • RAPADILINO syndrome
    • Diamond-Blackfan anemia 1

Fertility Preservation Discussion

  • Important for children and adolescent/young adult patients
  • Should be discussed before starting treatment
  • Fertility preservation methods should be offered when appropriate 1

Common Pitfalls to Avoid

  1. Delayed Diagnosis

    • Pain may be intermittent initially and confused with growing pains or musculoskeletal injury
    • Maintain high index of suspicion in adolescents with persistent bone pain
  2. Inadequate Imaging

    • Relying solely on plain radiographs
    • Not performing complete metastatic workup
  3. Improper Biopsy

    • Poorly planned biopsy can compromise limb-salvage surgery
    • Biopsy should be performed at the treating center by the surgical team
  4. Missing Skip Lesions

    • Failure to detect skip metastases can lead to inadequate surgical planning
    • MRI of the entire bone is essential

Prognostic Factors to Assess

  • Tumor site and size
  • Patient age and sex
  • Presence and location of metastases
  • Surgical margins achievability
  • Response to neoadjuvant chemotherapy 1

The comprehensive initial workup is crucial for accurate staging and treatment planning, which directly impacts patient survival. The 5-year survival rate for osteosarcoma is approximately 68% overall, but outcomes are significantly better with early detection and appropriate management 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Classification, imaging, biopsy and staging of osteosarcoma.

Indian journal of orthopaedics, 2014

Research

The epidemiology of osteosarcoma.

Cancer treatment and research, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.